Dusan Rasic

4PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 20, 2026
Level of estrogen receptor expression, histological grade, and computationally assessed stromal TILs on pre-treatment biopsies predict pathological complete response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.

|Oct 07, 2025
AI assessment of tumor-infiltrating lymphocytes on routine H&E-slides as a predictor of response to neoadjuvant therapy in breast cancer-a real-world study.

Dusan Rasic, Elisabeth Ida Specht Stovgaard, Anne Marie Bak Jylling

|Aug 11, 2025
Effects of Supervised Exercise during Neoadjuvant Chemotherapy on Tumor Response in Patients with Breast Cancer (Neo-train): A Randomized Controlled Trial.

Eva Kjeldsted, Gunn Ammitzbøll, Anne-Vibeke Lænkholm

|Aug 24, 2023
A Multi-Stain Breast Cancer Histological Whole-Slide-Image Data Set from Routine Diagnostics.

Philippe Weitz, Masi Valkonen, Leslie Solorzano

Pageof 1

Frequent Collaborators

1 joint publications

Philippe Weitz

1 joint publications

Masi Valkonen

1 joint publications

Kimmo Kartasalo

1 joint publications

Sonja Koivukoski